Allurion Technologies' gastric balloon and Novo Nordisk's semaglutide achieved 20.3% weight loss in a trial. Read more here.

Roth MKM keeps a Buy rating and $16 price target on Allurion Technologies (ALUR) after its initial results from Allurion Program-GLP-1 combo.

One of the ways that federal scientists obtain vital weather data is being curtailed by budget cuts from Elon Musk's Department of Government Efficiency, or DOGE. At least 11 National Weather ...

Is the promise of rapid weight loss worth having 80% of your stomach removed? It was for Remi Bader, a NYC-based influencer who became popular for her “realistic, plus-sized try-ons.” ...

Atlantic Medical Group- AMG weight loss Center now offers the Spatz3 Intragastric Balloon, an FDA-approved, adjustable, non-surgical weight loss solution in NC. Introducing the Spatz procedure is ...

DJ Morrow’s creations, inspired by his own emotional life, can disturb as much as they delight. Credit... Supported by By Joshua David Stein Photographs and Video by Jake Michaels “It’s ...

L to R: Zach Cherry, Britt Lower, Adam Scott, Tramell Tillman, Gwendoline Christie and Dan Erickson surprise London commuters on their way to work at a "Severance" installation at the More London ...

The seamless, poreless, sanitized effigy of a capitalist titan was a startling piece of marketing for Skims. By Rhonda Garelick Rhonda Garelick writes the Face Forward column for The New York ...

Gastric cancer, or stomach cancer, is a type of cancer that begins in the mucus-producing cells on the inside lining of the stomach. The most common type of stomach cancer is adenocarcinoma.